While GIGYF2 has been implicated in diverse pathological conditions, including metabolic diseases, vascular aging, viral infections, and neurodegenerative disorders, the molecular mechanisms identified in disease contexts remain limited and often correlative rather than mechanistically definitive. Here, GIGYF2 is linked to metabolic disease.